What is it about?
In this study we aimed to further explore the relationship between the elevations of liver transaminases and inflammatory markers in adult patients with COVID-19.
Featured Image
Photo by Fusion Medical Animation on Unsplash
Why is it important?
The study shows that liver transaminases are complementary markers of COVID-19 severity. IL-2 emerges as a potential marker for borderline transaminase elevations, whereas IL-10 is mainly associated with moderate to severe transaminase elevations in COVID-19 patients.
Perspectives
The associations found in this study reflect the continuous dynamics interplay between viral infection and the immune response, and its consequences for COVID-19 severity.
Dr Marcia R Cominetti
Federal University of Sao Carlos
Read the Original
This page is a summary of: Elevations in Liver Transaminases in COVID-19: (How) Are They Related?, Frontiers in Medicine, July 2021, Frontiers,
DOI: 10.3389/fmed.2021.705247.
You can read the full text:
Contributors
The following have contributed to this page
